Advances in Pediatric Personalized Medicine Take Center Stage at First-of-Its-Kind International Conference

KANSAS CITY, Mo., April 21 /PRNewswire/ –

                   The world's leading experts in pediatric
                   pharmacogenomics and personalized medicine are
                   gathering at a first-of-its-kind conference in
                   Kansas City to change the way childhood diseases and
                   illnesses are treated through personalized medicine.
                   Details can be found at http://www.regonline.com/
    WHAT           builder/site/Default.aspx?eventid=787610

    WHEN          April 28-30, 2010
                   Children's Mercy Hospitals and Clinics, 2401 Gillham
    WHERE          Road, Kansas City, Mo.
    WHO           Conference organizers available for interviews:

                   --Stephen Spielberg, MD, PhD, Director of the
                   Children's Mercy Center for Personalized Medicine and
                   Therapeutic Innovation
                   --J. Steven Leeder, PharmD, PhD, Division Chief,
                   Clinical Pharmacology and Medical Toxicology,
                   Children's Mercy Hospitals and Clinics
                  Other experts available upon request.
                   Personalized medicine continues to be an important
                   area of focus for pediatric patients, as hospitals
                   and clinics across the country seek ways to tailor
                   therapy for patients to improve outcomes and reduce
                   costs. The implications of this shift are profound,
                   and experts from academia, government and the private
                   sector in the US, Canada and Japan are convening to
                   exchange knowledge on clinical applications,
                   bioethics and development of pediatric personalized
    WHY            medicine programs.

                   Children's Mercy Hospitals and Clinics is a national
                   leader in pediatric personalized medicine and is
                   launching two new programs - the outpatient
                   Personalized Medicine and Therapeutic Innovation
                   Clinic and an inpatient adverse drug reaction program
                   to improve medication safety. The clinics will
                   receive referrals for patients who present diagnostic
                   and therapeutic challenges - those patients who are
                   not responding to current therapy, as well as those
                   who have had an unexpected, adverse reaction to a
                   medication. Using a variety of approaches, including
                   genomic technologies and collaboration between
                   clinical pharmacologists and pediatric
                   subspecialists, the personalized medicine clinic at
                   Children's Mercy will provide more targeted choice of
                   therapies for treatment of the pediatric population.
    CONTACT       Sherry D. Gibbs | (816) 346-1340 | SDGibbs@cmh.edu

SOURCE Children’s Mercy Hospitals and Clinics